Liver-brain interactions in inflammatory liver diseases: Implications for fatigue and mood disorders

Brain, Behavior, and Immunity

Volumn 35, Issue , 2014, Pages 9-20

  D'Mello, Charlotte ^a   Swain, Mark G ^a  

^a UNIVERSITY OF CALGARY   (Canada)

Author keywords

Cytokines; Hepatic inflammation; Microglia; Monocytes; Mood disorders; Sickness behaviors

Indexed keywords

ANTIDEPRESSANT AGENT; GAMMA INTERFERON; IMMUNOSUPPRESSIVE AGENT; INTERLEUKIN 17; INTERLEUKIN 1BETA; INTERLEUKIN 6; MONOCYTE CHEMOTACTIC PROTEIN 1; NATALIZUMAB; ONDANSETRON; PADGEM PROTEIN; SEROTONIN 1A AGONIST; TROPISETRON; TUMOR NECROSIS FACTOR ALPHA;

BECK DEPRESSION INVENTORY; CROHN DISEASE; CYTOKINE PRODUCTION; DEPRESSION; DRUG EFFECT; EVOKED MUSCLE RESPONSE; FATIGUE; FORCED SWIMMING TEST; HEPATITIS; HEPATITIS C; HUMAN; ILLNESS BEHAVIOR; IMMUNOSUPPRESSIVE TREATMENT; LIVER BRAIN INTERACTION; LIVER CELL; LIVER GRAFT REJECTION; LIVER TRANSPLANTATION; LOCOMOTION; MACROPHAGE; MICROGLIA; MONOCYTE; MOOD DISORDER; NONHUMAN; PRIORITY JOURNAL; REVIEW; TISSUE INTERACTION; TRANSCRANIAL MAGNETIC STIMULATION; ANIMAL; BRAIN; IMMUNOLOGY; IMMUNOMODULATION; LIVER; MOUSE; PATHOPHYSIOLOGY; RAT;

ANIMALS; BRAIN; FATIGUE; HEPATITIS; HUMANS; LIVER; MICE; MOOD DISORDERS; NEUROIMMUNOMODULATION; RATS;

EID: 84888879343     PISSN: 08891591     EISSN: 10902139     Source Type: Journal    
DOI: 10.1016/j.bbi.2013.10.009     Document Type: Review

References (117)

1. Audoy-Remus J., Richard J.-F., Soulet D., Zhou H., Kubes P., Vallieres L. Rod-shaped monocytes patrol the brain vasculature and give rise to perivascular macrophages under the influence of proinflammatory cytokines and angiopoietin-2. J. Neurosci. 2008, 28:10187-10199.
2. Auffray C., Sieweke M.H., Geissmann F. Blood monocytes: development, heterogeneity, and relationship with dendritic cells. Annu. Rev. Immunol. 2009, 27:669-692.
3. Babatin M.A., Sanai F.M., Swain M.G. Methotrexate therapy for the symptomatic treatment of primary biliary cirrhosis patients, who are biochemical incomplete responders to ursodeoxycholic acid therapy. Aliment. Pharmacol. Ther. 2006, 24:813-820.
4. Bladowska J., Zimny A., Knysz B., Malyszczak K., Koltowska A., Szewczyk P., Gasiorowski J., Furdal M., Sasiadek M.J. Evaluation of early cerebral metabolic, perfusion and microstructural changes in HCV-positive patients: a pilot study. J. Hepatol. 2013, 59:651-657.
5. Bluthe R.M., Michaud B., Kelley K.W., Dantzer R. Vagotomy blocks behavioral effects of interleukin-1 injected via the intraperitoneal route but not via other systemic routes. Neuroreport 1996, 7:2823-2827.
6. Bluthe R.M., Laye S., Michaud B., Combe C., Dantzer R., Parnet P. Role of interleukin-1b and tumor necrosis factor-a in lipopolysaccharide-induced sickness behavior: a study with interleukin-1 type 1 receptor-deficient mice. Eur. J. Neurosci. 2000, 12:4447-4456.
7. Bluthe R.M., Kelley K.W., Dantzer R. Effects of insulin-like growth factor-I on cytokine-induced sickness behavior in mice. Brain Behav. Immun. 2006, 20:57-63.
8. Bogdanos D.P., Gao B., Gershwin M.E. Liver immunology. Compr. Physiol. 2013, 3:567-598.
9. Bona M.D., Ponton P., Ermani M., Lemmolo R.M., Feltrin A., Boccagni P., Gerunda G., Naccarato R., Rupolo G., Burra P. The impact of liver disease and medical complications on quality of life and psychological distress before and after liver transplantation. J. Hepatol. 2000, 33:609-615.
10. Burak K.W., Le T., Swain M.G. Increased midbrain 5-HT1A receptor number and responsiveness in cholestatic rats. Brain Res. 2001, 892:376-379.
11. Burak K.W., Le T., Swain M.G. Increased sensitivity to the locomotor-activating effects of corticotropin-releasing hormone in cholestatic rats. Gastroenterology 2002, 122:681-688.
12. Campbell S.J., Perry V.H., Pitossi F.J., Butchart A.G., Chertoff M., Waters S., Dempster R., Anthony D.C. Central nervous system injury triggers hepatic CC and CXC chemokine expression that is associated with leukocyte mobilization and recruitment to both central nervous system and the liver. Am. J. Pathol. 2005, 166:1487-1497.
13. Campbell S.J., Deacon R.M.J., Jiang Y., Ferrari C., Pitossi F.J., Anthony D.C. Overexpression of IL-1b by adenoviral-mediated gene transfer in the rat brain causes a prolonged hepatic chemokine response, axonal injury and the suppression of spontaneous behavior. Neurobiol. Dis. 2007, 27:151-163.
14. Campbell S.J., Jiang Y., Davis A.E.M., Farrands R., Holbrook J., Leppert D., Anthony D.C. Immunomodulatory effects of etanercept in a model of brain injury act through attenuation of the acute-phase response. J. Neurochem. 2007, 103:2245-2255.
15. Campbell S.J., Anthony D.C., Oakley F., Carlsen H., Elsharkawy A.M., Blomhoff R., Mann D.A. Hepatic nuclear factor kb regulates neutrophil recruitment to the injured brain. J. Neuropathol. Exp. Neurol. 2008, 67:223-230.
16. Campbell S.J., Zahid I., Losey P., Law S., Jiang Y., Bilgen M., van-Rooijen N., Morsali D., Davis A.E.M., Anthony D.C. Liver Kupffer cells control the magnitude of the inflammatory response in the injured brain and spinal cord. Neuropharmacology 2008, 55:780-787.
17. Capuron L., Ravaud A., Neveu P.J., Miller A.H., Maes M., Dantzer R. Association between decreased serum tryptophan concentrations and depressive symptoms in cancer patients undergoing cytokine therapy. Mol. Psychiatry 2002, 7:468-473.
18. Cerri G., Cocchi C.A., Montagna M., Zuin M., Podda M., Cavallari P., Selmi C. Patients with primary biliary cirrhosis do not show post-exercise depression of cortical excitability. Clin. Neurophysiol. 2010, 121:1321-1328.
19. Chaudhuri A., Behan P.O. Fatigue and basal ganglia. J. Neurol. Sci. 2000, 179:34-42.
20. Cheng C.-W., Duwaerts C.C., van-Rooijen N., Wintermeyer P., Mott S., Gregory S.H. NK cells suppress experimental cholestatic liver injury by an interleukin-6-mediated, Kupffer cell-dependent mechanism. J. Hepatol. 2011, 54:746-752.
21. Ching S., Zhang H., Belevych N., He L., Lai W., Pu X., Jaeger L.B., Chen Q., Quan N. Endothelial-specific knockdown of interleukin-l (IL-1) type 1 receptor differentially alters CNS responses to IL-1 depending on its route of administration. J. Neurosci. 2007, 27:10476-10486.
22. Contarino A., Dellu F., Koob G.G., Smith G.W., Lee K., Vale W.W., Gold L.H. Dissociation of locomotor activity and suppression of food intake induced by CRF in CRFR1-deficient mice. Endocrinology 2000, 141:2698-2702.
23. Corona A.W., Huang Y., O'Connor J.C., Dantzer R., Kelly K.W., Popovich P.G., Godbout J.P. Fractalkine receptor (CX3CR1) deficiency sensitizes mice to the behavioral changes induced by lipopolysaccharide. J. Neuroinflamm. 2010, 7.
24. Dantzer R., O'Connor J.C., Freund G.C., Johnson R.W., Kelley K.W. From inflammation to sickness and depression: when the immune system subjugates the brain. Nat. Rev. Neurosci. 2008, 9:46-56.
25. de-Paiva V.N., Lima S.N., Fernandes M.M., Soncini R., Andrade C.A., Giusti-Paiva A. Prostaglandins mediate depressive-like behavior induced by endotoxin in mice. Behav. Brain Res. 2010, 215:146-151.
26. DMello C., Swain M.G. Liver-brain inflammation axis. Am. J. Physiol. Gastrointest. Liver Physiol. 2011, 301:G749-G761.
27. D'Mello C., Le T., Swain M. Cerebral microglia recruit monocytes into the brain in response to tumor necrosis factor signaling during peripheral organ inflammation. J. Neurosci. 2009, 29:2089-2102.
28. D'Mello C., Riazi K., T L., Stevens K.M., A W., McKay D.M., Pittman Q., Swain M.G. P-selectin-mediated monocyte-cerebral endothelium adhesive interactions link peripheral organ inflammation to sickness behaviors. J. Neurosci. 2013, 33:14878-14888.
29. Duwaerts C.C., Gehring S., Cheng C.-W., van-Rooijen N., Gregory S.H. Contrasting responses of Kupffer cells and inflammatory mononuclear phagocytes to biliary obstruction in a mouse model of cholestatic liver injury. Liver Int. 2013, 33:255-265.
30. Ek M., Kurosawa M., Lundeberg T., Ericsson A. Activation of vagal afferents after intravenous injection of interleukin-1beta: role of endogenous prostaglandins. J. Neurosci. 1998, 18:9471-9479.
31. Ellingsen T., Hornung N., Kuno Moller B., Poulsen J.H., Stengaard-Pedersen K. Up-regulation of CCR2 on circulating monocytes is a potential predictor of methotrexate response in active chronic rheumatoid arthritis. Ann. Rheum. Dis. 2006, 2-19.
32. Forestiero D., Manfrim C.M., Guimaraes F.S., de-Oliveira R.M. Anxiolytic-like effects induced by nitric oxide synthase inhibitors microinjected into the medial amygdala of rats. Psychopharmacology 2006, 182:166-172.
33. Forton D.M., Patel N., Prince M., Oatridge A., Hamilton G., Goldblatt J., Allsop J.M., Hajnal J.V., Thomas H.C., Bassendine M., Jones D.E., Taylor-Robinson S.D. Fatigue and primary biliary cirrhosis: association of globus pallidus magnetisation transfer ratio measurements with fatigue severity and blood manganese levels. Gut 2004, 53:587-592.
34. Forton D.M., Hamilton G., Allsop J.M., Grover V.P., Wesnes K., O'Sullivan C., Thomas H.C., Taylor-Robinson S.D. Cerebral immune activation in chronic hepatitis C infection: a magnetic resonance spectroscopy study. J. Hepatol. 2008, 49:316-322.
35. Geissmann F., Jung S., Littman D.R. Blood monocytes consist of two principal subsets with distinct migratory properties. Immunity 2003, 19:71-82.
36. Gold P.W., Chrousos G.P. Organization of the stress system and its dysregulation in melancholic and atypical depression: high vs. low CRH/NE states. Mol. Psychiatry 2002, 7:254-275.
37. Grover V.P.B., Pavese N., Koh S.-B., Wyzlezinska M., Saxby B.K., Gerhard A., Forton D.M., Brooks D.J., Thomas H.C., Taylor-Robinson S.D. Cerebral microglial activation in patients with hepatitis C: in vivo evidence of neuroinflammation. J. Viral Hepat. 2012, 19:e89-e96.
38. Gruys E., Toussaint M.J.M., Niewold T.A., Koopmans S.J. Acute phase reaction and acute phase proteins. J. Zhejiang Univ. Sci. 2005, 6:1045-1056.
39. Guilarte T.R. Manganese toxicity: new perspectives from behavioral, neuroimaging and neuropathological studies in humans and non-human primates. Front. Aging Neurosci. 2013, 5.
40. Hannestad J., Subramanyam K., DellaGioia N., Planeta-Wilson B., Weinzimmer D., Pittman B., Carson R.E. Glucose metabolism in the insula and cingulate is affected by systemic inflammation in humans. J. Nucl. Med. 2012, 53:601-607.
41. Harrison N.A., Brydon L., Walker C., Gray M.A., Steptoe A., Dolan R.J., Critchley H.D. Neural origins of human sickness in interoceptive responses to inflammation. Biol. Psychiatry 2009, 66:415-422.
42. Harty M.W., Papa E.F., Huddleston H.M., Young E., Nazareth S., Riley C.A., Ramm G.A., Gregory S.H., Tracy T.F. Hepatic macrophages promote the neutrophil-dependent resolution of fibrosis in repairing cholestatic rat livers. Surgery 2008, 143:667-678.
43. Henry C.J., Huang Y., Wynne A., Hanke M., Himler J., Bailey M.T., Sheridan J.F., Godbout J.P. Minocycline attenuates lipopolysaccharide (LPS)-induced neuroinflammation, sickness behavior and anhedonia. J. Neuroinflamm. 2008, 5.
44. Hou L., Jie Z., Desai M., Liang Y., Soong L., Wang T., Sun J. Early IL-17 production by intrahepatic T cells is important for adaptive immune responses in viral hepatitis. J. Immunol. 2013, 190:621-629.
45. Huet P., Deslauriers J., Tran A., Faucher C., Charbonneau J. Impact of fatigue on the quality of life with patients with primary biliary cirrhosis. Am. J. Gastroenterol. 2000, 95:760-767.
46. Jones D.E.J., Bhala N., Burt J., Goldblatt J., Prince M., Newton J.L. Four year follow up of fatigue in a geographically defined primary biliary cirrhosis patient cohort. Gut 2006, 55:536-541.
47. Kaster M.P., Gadotti V.M., Calixto J.B., Santos A.R.S., Rodrigues A.L.S. Depressive-like behavior induced by tumor necrosis factor-a in mice. Neuropharmacology 2012, 62:419-426.
48. Kerfoot S.M., D'Mello C., Nguyen H., Ajuebor M.N., Kubes P., Le T., Swain M.G. TNF-a secreting monocytes are recruited into the brains of cholestatic mice. Hepatology 2006, 43:154-162.
49. Kobayashi Y. The regulatory role of nitric oxide in proinflammatory cytokine expression during the induction and resolution of inflammation. J. Leukoc. Biol. 2010, 88:1157-1162.
50. Kraus M.R., Schafer A., Schottker K., Keicher C., Weissbrich B., Hofbauer I., Scheurlen M. Therapy of interferon-induced depression in chronic hepatitis C with citalopram: a randomised, double-blind, placebo-controlled study. Gut 2008, 57:531-536.
51. Lacroix S., Rivest S. Effect of acute systemic inflammatory response and cytokines on the transcription of the genes encoding cyclooxygenase enzymes (COX-1 and COX-2) in the rat brain. J. Neurochem. 1998, 70:452-466.
52. Laflamme N., Rivest S. Effects of systemic immunogenic insults and circulating proinflammatory cytokines on the transcription of the inhibitory factor kBa within specific cellular populations of the rat brain. J. Neurochem. 1999, 73:309-321.
53. Lasselin L., Laye S., Dexpert S., Aubert A., Gonzalez C., Gin H., Capuron L. Fatigue symptoms relate to systemic inflammation in patients with type 2 diabetes. Brain Behav. Immun. 2012, 26:1211-1219.
54. Lawson M.A., McCusker R.H., Kelly K.W. Interleukin-1 beta converting enzyme is necessary for development of depression-like behavior following intracerebroventricular administration of lipopolysaccharide to mice. J. Neuroinflamm. 2013, 10.
55. Lee W., Moriarty T.J., Wong C.H.Y., Zhou H., Strieter R.M., Rooijen N.V., Chaconas G., Kubes P. An intravascular immune response to Borrelia burgdorferi involves Kupffer cells and iNKT cells. Nat. Immunol. 2010, 11:295-303.
56. Lichtenstein G.R., Bala M., Han C., DeWoody K., Schaible T. Infliximab improves quality of life in patients with Crohn's disease. Inflamm. Bowel Dis. 2002, 8:237-243.
57. Loftis J.M., Huckans M., Ruimy S., Hinrichs D.J., Hauser P. Depressive symptoms in patients with chronic hepatitis C are correlated with elevated plasma levels of interleukin-1b and tumor necrosis factor-a. Neurosci. Lett. 2008, 430:264-268.
58. Louis E., Belaiche J., van-Kemseke C., Frachimont D., de-Groote D., Gueenen V., Mary J.Y. A high serum concentration of interleukin-6 is predictive of relapse in quiescent Crohn's disease. Eur. J. Gastroenterol. Hepatol. 1997, 9:939-944.
59. Lucki I. The spectrum of behaviors influenced by serotonin. Biol. Psychiatry 1998, 44:151-162.
60. McDonald C., Newton J., Lai H.M., Baker S.N., Jones D.E. Central nervous system dysfunction in primary biliary cirrhosis and its relationship to symptoms. J. Hepatol. 2010, 53:1095-1100.
61. Melles G.F., Melles G.F., Pells G., Newton J.L., Bathgate A.J., Burroughs A.K., Heneghan M.A., Neuberger J.M., Day D.B., Ducker S.J., Sandford R.N., Alexander G.J., Jones D.E.J. Impact of primary biliary cirrhosis on perceived quality of life: the UK-PBC national study. Hepatology 2013, 25:273-283. UK-PBC-Consortium.
62. Miller A.H., Haroon E., Raison C.L., Felger J.C. Cytokine targets in the brain: impact on neurotransmitters and neurocircuits. Depress. Anxiety 2013, 30:297-306.
63. Moller A., Wiedemann G., Rohde U., Backmund H., Sonntag A. Correlates of cognitive impairment and depressive mood disorder in multiple sclerosis. Acta Psychiatr. Scand. 1994, 89:117-121.
64. Nadeau S., Rivest S. Effects of circulating tumor necrosis factor-a on the neuronal activity and expression of the genes encoding the tumor necrosis factor receptors (p55 and p75) in the rat brain: a view from the blood-brain barrier. Neuroscience 1999, 93:1449-1464.
65. Neuman M., Angulo P., Malkiewicz I., Jorgensen R., Shear N., Dickson E.R., Haber J., Katz G., Lindor K. Tumor necrosis factor-alpha and transforming growth factor-beta reflect severity of liver damage in primary biliary cirrhosis. J. Gastroenterol. Hepatol. 2002, 17:196-202.
66. Newton J.L., Gibson G.J., Tomlinson M., Wilton K., Jones D. Fatigue in primary biliary cirrhosis is associated with excessive daytime sleepiness. Hepatology 2006, 44:91-98.
67. Newton J.L., Hollingsworth K.G., Taylor R., El-Sharkawy A.M., Khan Z.U., Pearce R., Sutcliffe K., Okonkwo O., Davidson A., Burt J., Blamire A.M., Jones D. Cognitive impairment in primary biliary cirrhosis: symptom impact and potential etiology. Hepatology 2008, 48:541-549.
68. Nguyen H., Wang H., Le T., Ho W., Sharkey K., Swain M.G. Downregulated hypothalamic 5-HT3 receptor expression and enhanced 5HT3 receptor antagonist mediated improvement in fatigue like behavior in cholestatic rats. Neurogastroenterol. Motil. 2007, 20:228-235.
69. Nguyen K., D'Mello C., Le T., Urbanski S., Swain M.G. Regulatory T cells suppress sickness behaviour development without altering liver injury in cholestatic mice. J. Hepatol. 2012, 56:626-631.
70. Nikkila H.V., Muller K., Ahokas A., Miettinen K., Rimon R., Andersson L.C. Accumulation of macrophages in the CSF of schizophrenic patients during acute psychotic episodes. Am. J. Psychiatry 1999, 156:1725-1729.
71. O'Connor J.C., Andre C., Wang Y., Lawson M.A., Szegedi S.S., Lestage J., Castanon N., Kelley K.W., Dantzer R. Interferon-g and tumor necrosis factor-a mediate the upregulation of indoleamine 2,3-dioxygenase and the induction of depressive-like behavior in mice in response to Bacillus Calmette-Guerin. J. Neurosci. 2009, 29:4200-4209.
72. Oeckinghaus A., Hayden M.S., Ghosh S. Crosstalk in NF-kb signaling pathways. Nat. Immunol. 2011, 12:695-708.
73. Padmos R.C., Hillegers M.H.J., Knijff E.M., Vonk R., Bouvy A., Staal F.J.T., Ridder D.D., Kupka R.W., Nolen W.A., Drexhage H.A. A discriminating messenger RNA signature for bipolar disorder formed by an aberrant expression of inflammatory genes in monocytes. Arch. Gen. Psychiatry 2008, 65:395-407.
74. Palkonyai E., Kolarz G., Kopp M., Bogye G., Temesvari P., Palkonyay L., Ratko I., Meszaros E. Depressive symptoms in early rheumatoid arthritis: a comparative longitudinal study. Clin. Rheumatol. 2007, 26:753-758.
75. Pan W., Zadina J.E., Harlan R.E., Weber J.T., Banks W.A., Kastin A.J. Tumor Necrosis factor-a; a neuromodulator in the CNS. Neurosci. Biobehav. Rev. 1997, 21:603-613.
76. Philip Wintermeyer C.W.C., Gehring Stephan, Hoffman Beth L., Holub Martin, Brossay Laurent, Gregory Stephen H. Invariant natural killer T cells suppress the neutrophil inflammatory response in a mouse model of cholestatic liver damage. Gastroenterology 2009, 136:1048-1059.
77. 3 receptor antagonist, on fatigue in chronic hepatitis C: a randomised, double-blind, placebo controlled study. Gut 2005, 54:1169-1173.
78. Putzki N., Yaldizli Ã.Z.R., Tettenborn B., Diener H.C. Multiple sclerosis associated fatigue during natalizumab treatment. J. Neurol. Sci. 2009, 285:109-113.
79. Qin L., Wu X., Block M.L., Liu Y., Breese G.R., Hong J.S., Knapp D.J., Crews F.T. Systemic LPS causes chronic neuroinflammation and progressive neurodegeneration. Glia 2007, 55:453-462.
80. Quan N., Whiteside M., Kim L., Herkenham M. Induction of inhibitory factor kBa mRNA in the central nervous system after peripheral lipopolysaccharide administration: an in situ hybridization histochemistry study in the rat. Proc. Natl. Acad. Sci. 1997, 94:10985-10990.
81. Raison C.L., Borisov A.S., Majer M., Drake D.F., Pagnoni G., Woolwine B.J., Vogt G.J., Massung B., Miller A.H. Activation of central nervous system inflammatory pathways by interferon-alpha: relationship to monoamines and depression. Biol. Psychiatry 2009, 65.
82. Raison C.L., Dantzer R., Kelley K.W., Lawson M.A., Woolwine B.J., Vogt G., Spivey J.R., Saito K., Miller A.H. CSF concentrations of brain tryptophan and kynurenines during immune stimulation with IFN-a: relationship to CNS immune responses and depression. Mol. Psychiatry 2010, 15:393-403.
83. Raison C.L., Dantzer R., Kelley K.W., Lawson M.A., Woolwine B.J., Vogt G., Spivey J.R., Saito K., Miller A.H. CSF concentrations of brain tryptophan and kynurenines during immune stimulation with IFN-a: relationship to CNS immune responses and depression. Mol. Psychiatry 2010, 15:393-403.
84. Rech J., Hess A., Finzel S., Kreitz S., Sergeeva M., Englbrecht M., Doerfler A., Saake M., Schett G. Association of brain functional magnetic resonance activity with response to tumor necrosis factor inhibition in rheumatoid arthritis. Arthritis Rheum. 2013, 65:325-333.
85. Riccio A., Postiglione L., Sabatini P., Linvelli M., Soriente I., Sangiolo M.G., Amato P., Tarantino G. Similar serum levels of IL-6 and its soluble receptors in patients with HCV-related arthritis and rheumatoid arthritis: a pilot study. Int. J. Immunopathol. Pharmacol. 2012, 25:281-285.
86. Ridder D.A., Lang M.-F., Salinin S., Roderer J.-P., Struss M., Maser-Gluth C., Schwaninger M. TAK1 in brain endothelial cells mediates fever and lethargy. J. Exp. Med. 2011, 208:2615-2623.
87. Rivest S., Lacroix S., Vallieres L., Nadeau S., Zhang J., Laflamme N. How the blood talks to the brain parenchyma and the paraventricular nucleus of the hypothalamus during systemic inflammatory and infectious stimuli. Proc. Soc. Exp. Biol. Med. 2000, 223:22-38.
88. Roussaki-Schulze A.V., Kouskoukis C., Petinaki E., Klimi E., Zafiriou E., Galanos A., Rallis E. Evaluation of cytokine serum levels in patients with plaque-type psoriasis. Int. J. Clin. Pharmacol. Res. 2005, 25:169-173.
89. Sarkar S., Jiang Z., Evon D.M., Wahed A.S., Hoofnagle J.H. Fatigue before, during and after antiviral therapy of chronic hepatitis C: results from the Virahep-C study. J. Hepatol. 2012, 57:946-952.
90. Schulz M., Engelhardt B. The circumventricular organs participate in the immunopathogenesis of experimental autoimmune encephalomyelitis. Cerebrospinal Fluid Res. 2005, 2.
91. Schwartz M. "Tissue-repairing" blood derived macrophages are essential for healing of the injured spinal cord: from skin-activated macrophages to infiltrating blood-derived cells?. Brain Behav. Immun. 2010, 24:1054-1057.
92. Seidel A., Arolt V., Hunstiger M., Rink L., Behnisch A., Kirchner H. Major depressive disorder is associated with elevated monocyte counts. Acta Psychiatr. Scand. 1996, 94:198-204.
93. Selmi C., Mackay I.R., Gershwin M.E. The immunological mileu of the liver. Semin. Liver Dis. 2007, 27:129-138.
94. Steiner J., Walter M., Gos T., Guillemin G.J., Bernstein H.-G., Sarnyai Z., Mawrin C., Brisch R., Bielau H., Schwabedissen L.M.Z., Bogerts B., Myint A.-M. Severe depression is associated with increased microglial quinolic acid in subregions of the anterior cingulate gyrus: evidence for an immune-modulated glutamatergic neurotransmission. J. Neuroinflamm. 2011, 8.
95. Strand V., Burmester G.R., Ogale S., Devenport J., John A., Emery P. Improvements in health-related quality of life after treatment with tocilizumab in patients with rheumatoid arthritis refractory to tumour necrosis factor inhibitors: results from the 24-week randomized controlled RADIATE study. Rheumatology 2012, 51:1860-1869.
96. Svenningsson A., Falk E., Celius E.G., Fuchs S., Schreiber K., Berko S., Sun J., Penner I.-K. Natalizumab treatment reduces fatigue in multiple sclerosis. Results from the TYNERGY trial; a study in the real life setting. PLoS One 2013, 8. Tynergy-trial-Investigators.
97. Swain M.G. Hepatic NKT cells: friend or foe?. Clin. Sci. 2008, 114:457-466.
98. Swain M.G., Le T. Chronic cholestasis in rats induces anhedonia and a loss of social interest. Hepatology 1998, 28:6-10.
99. Swain M.G., Maric M. Defective corticotropin-releasing hormone mediated neuroendocrine and behavioral responses in cholestatic rats: implications for cholestatic liver disease-related sickness behaviors. Hepatology 1995, 1560-1564.
100. Swain M.G., Maric M. Impaired stress and interleukin-1b induced hypothalamic expression of the neuronal activation marker Fos in cholestatic rats. Hepatology 1996, 24:914-918.
101. Swain M.G., Maric M. Improvement in cholestasis associated fatigue with a serotonin receptor agonist using a novel rat model of fatigue assessment. Hepatology 1997, 25:291-294.
102. Swain M.G., Mogiakou M.A., Bergassa N.V., Chrousos G.P. Facilitation of ACTH and cortisol responses to corticotropin-releasing hormone (CRH) in patients with primary biliary cirrhosis. Hepatology 1994, 20:A197.
103. Targan S.R., Feagan B.G., Fedorak R.N., Lashner B.A., Pannaccione R., Present D.H., Spehlmann M.E., Rutgeerts P.J., Tulassay Z., Volfova M., Wolf D.C., Hernandez C., Bornstein J., Sandborn W.J. Natalizumab for the treatment of active Crohn's disease: results of the ENCORE trial. Gastroenterology 2007, 132:1672-1683.
104. Thibeault I., Laflamme N., Rivest S. Regulation of the gene encoding the Monocyte Chemoattractant Protein 1 (MCP-1) in the mouse and rat brain in response to circulating LPS and proinflammatory cytokines. J. Comp. Neurol. 2001, 434:461-477.
105. Tsigos C., Chrousos G.P. Hypothalamic-pituitary-adrenal axis, neuroendocrine factors and stress. J. Psychosom. Res. 2002, 53:865-871.
106. Vallieres L., Rivest S. Regulation of the genes encoding interleukin-6, its receptor and gp130 in the rat brain in response to the immune activator lipopolysaccharide and the proinflammatory cytokine interleukin-1b. J. Neurochem. 1997, 69:1668-1683.
107. van Ginneken B.T.J., van den Berg-Emons R.J.G., van der Windt A., Tilanus H.W., Metselaar H.J., Stam H.J., Kazemier G. Persistent fatigue in liver transplant recipients: a two year follow-up study. Clin. Transpl. 2010, 24:E10-E16.
108. van Os E., van den Broek W.W., Mulder P.G., ter Borg P.C., Bruijn J.A., van Buuren H.R. Depression in patients with primary biliary cirrhosis and primary sclerosing cholangitis. J. Hepatol. 2007, 46:1099-1103.
109. Vercoulen J.H., Bazelmans E., Swanink C.M., Fennis J.F., Galama J.M., Jongen P.J., Hommes O., Meer J.W.V.D., Bleijenberg G. Physical activity in chronic fatigue syndrome: assessment and its role in fatigue. J. Psychiatr. Res. 1997, 31:661-673.
110. Vermijlen D., Luo D., Froelich C.J., Medema J.P., Kummer J.A., Willems E., Braet F., Wisse E. Hepatic natural killer cells exclusively kill splenic/blood natural killer-resistant tumor cells by the perforin/granzyme pathway. J. Leukoc. Biol. 2002, 72:668-676.
111. Wan W., Janz L., Vriend C.Y., Sorensen C.M., Greenberg A.H., Nance D.M. Differential induction of c-Fos immunoreactivity in hypothalamus and brain stem nuclei following central and peripheral administration of endotoxin. Brain Res. Bull. 1993, 32:581-587.
112. Weissenborn K., Ennen J.C., Bokemeyer M., Ahl B., Wurster U., Tillmann H., Trebst C., Hecker H., Berding G. Monoaminergic neurotransmission is altered in hepatitis C virus infected patients with chronic fatigue and cognitive impairment. Gut 2006, 55:1624-1630.
113. Wohleb E.S., Powell N.D., Godbout J.P., Sheridan J.F. Stress-induced recruitment of bone marrow-derived monocytes to the brain promotes anxiety-like behavior. J. Neurosci. 2013, 33:13820-13833.
114. Yamamoto T., Azechi H., Board M. Essential role of excessive tryptophan and its neurometabolites in fatigue. Can. J. Neurol. Sci. 2012, 39:40-47.
115. Yang K., Xie G., Zhang Z., Wang C., Li W., Zhou W., Tang Y. Levels of serum interleukin (IL)-6, IL-1beta, tumour necrosis factor-alpha and leptin and their correlation in depression. Aust. N Z J Psychiatry 2007, 41:266-273.
116. Zhang J., Rivest S. Distribution, regulation and colocalization of the genes encoding the EP2- and EP4-PGE2 receptors in the rat brain and neuronal responses to systemic inflammation. Eur. J. Neurosci. 1999, 11:2651-2668.
117. Zhang C.K., Hewett J., Hemming J., Grant T., Zhao H., Abraham C., Oikonomou I., Kanakia M., Cho J.H., Proctor D.D. The influence of depression on quality of life in patients with inflammatory bowel disease. Inflamm. Bowel Dis. 2013, 19:1732-1739.